NCT02695745View on ClinicalTrials.gov

Experimental Biomarker Study for Pain Thresholds

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Pain
Interventions
DRUG

V116517 aqueous suspension

300 mg (approximately 100 mL) aqueous suspension taken orally x 1 dose

DRUG

Celecoxib capsules

400 mg (2 capsules of 200 mg each) taken orally x 1 dose

DRUG

Placebo

Placebo for V116517 aqueous suspension taken orally x 1 dose and/or placebo for celecoxib, 2 capsules taken orally x 1 dose

DRUG

Capsaicin

1% administered topically

Trial Locations (1)

9000

CCBR A/S, Aalborg

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT02695745 - Experimental Biomarker Study for Pain Thresholds | Biotech Hunter | Biotech Hunter